K36 Therapeutics

Series-B+
k36tx.com Biotech & Healthcare Cambridge, United States Founded 2021 1-10
Total Funding $100M
Latest Round $70M Series-B+
Last Announced Jun 28, 2023
Investors 5 Backers
Decision Makers 1 Verified

About K36 Therapeutics

Targeting NSD2: Advancing Precision Medicine through Epigenetics.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Cambridge, United States
Year Founded 2021
Team Size 1-10
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website k36tx.com
Domain Registered Date Nov 12, 2020

Social & Network Presence

X / Twitter Profile @k36tx (40 followers) Created on Mar 2023
LinkedIn Corporate Not linked

Company Milestones & Timeline

5 Events
  1. Capital Raise

    Raised $70,000,000 · Series-B+

    fundraisingfox.com

  2. Milestone

    X account created (@k36tx)

    40 followers

  3. Capital Raise

    Raised $30,000,000 · Series-A

  4. Milestone

    Company founded

    Cambridge, United States

  5. Milestone

    Website domain registered

    k36tx.com

Investors & Backers

5
Atlas Venture
Bristol-Myers Squibb
Eight Roads Ventures
F-Prime Capital
Nextech Invest

Funding History

2 Rounds
Series-B+ · Jun 28, 2023
Series-A · Dec 9, 2021
$30,000,000 Source

Founders & Leadership

4

Benjamin Winograd

Chief Medical Officer

Work email & phone locked Unlock →

Shinta Cheng

Chief Medical Officer

Work email & phone locked Unlock →

Terrence Connolly

President and Chief Executive Officer

Work email & phone locked Unlock →

Yang Shi

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts